Search results
People also ask
Who is César Milstein?
How did Cesar Milstein die?
Why did César Milstein study antibody diversity?
Who were Cesar Milstein parents?
Mar 27, 2024 · César Milstein (born October 8, 1927, Bahía Blanca, Argentina—died March 24, 2002, Cambridge, England) was an Argentine-British immunologist who in 1984, with Georges Köhler and Niels K. Jerne, received the Nobel Prize for Physiology or Medicine for his work in the development of monoclonal antibodies. Milstein attended the Universities of ...
- The Editors of Encyclopaedia Britannica
Cesar Milstein was an Argentinian biochemist who received the Nobel Prize for his discovery of monoclonal antibody. Explore this biography to get details about his life, career and scientific discoveries.
Jun 1, 2002 · 10 Citations. 3 Altmetric. Metrics. In memoriam: César Milstein, who with the late Georges Köhler invented monoclonal antibodies, died on 24 March 2002. Their invention sprang from basic...
- Timothy A. Springer
- 2002
Mar 24, 2002 · Achievements. Milstein was important in advancing the knowledge of antibodies, notably their structure, expression and diversity. In 1984 he was awarded a Nobel Prize for his development, with Georges Kohler, of monoclonal antibodies in 1975.
- Bahia Blanca, Argentina
Apr 25, 2002 · Innovator in immunology Credit: MRC LMB. César Milstein began to study antibody diversity at a time when almost nothing was known about its molecular and genetic basis. As a logical step in...
- Klaus Rajewsky
- rajewsky@cbr.med.harvard.edu
- 2002
César Milstein. Nobel Prize in Physiology or Medicine 1984 for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies, shared with Niels Kaj Jerne and Georges Köhler. Department of Biochemistry PhD student (1958-1961, PhD awarded 1961).
May 17, 2002 · DOI: 10.1126/science.1073325. C ésar Milstein, the coinventor with Georges Köhler of monoclonal antibodies, died on 24 March 2002 at the age of 74. Monoclonal antibodies form one of the pillars of modern biotechnology and are indispensable tools for biomedical research.